Literature DB >> 3324304

Intestinal bacteria and rheumatic disease.

T Midtvedt1.   

Abstract

The striking clinical and pathological similarities between certain naturally occurring infectious diseases in animal species and those of some human rheumatic diseases, such as rheumatoid arthritis (RA), have stimulated the search for a microbial etiology of the latter syndrome. A long series of microbial species, including aerobic and anaerobic intestinal bacteria, mycoplasma and several viruses have been put into focus. Most often, however, an initially positive report has been followed by several reports denying an etiological role of the microbial species in focus. However, the concept of a microbial trigger in the etiology and symptomatology of RA is still a subject of intense debate. Recent results have indicated a reversed effect of gram-positive vs. gram-negative intestinal bacteria on adjuvant-induced arthritis in germfree rats and microbial peptidoglycans have been shown to play a major role in this experimental model. It has been shown that the intestinal flora may include bacteria containing antigenic determinant(s) cross-reacting with some markers within the HLA-system. The intestinal flora may also influence upon several digestive and absorptive functions and thereby acting upon parameters of importance in the development of rheumatic disease.

Entities:  

Mesh:

Year:  1987        PMID: 3324304     DOI: 10.3109/03009748709096721

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  11 in total

Review 1.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Role of enteric bacteria in the pathogenesis of rheumatoid arthritis: evidence for antibodies to enterobacterial common antigens in rheumatoid sera and synovial fluids.

Authors:  S Aoki; K Yoshikawa; T Yokoyama; T Nonogaki; S Iwasaki; T Mitsui; S Niwa
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

Review 3.  Colonization and impact of disease and other factors on intestinal microbiota.

Authors:  Oscar C Thompson-Chagoyán; José Maldonado; Angel Gil
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

4.  Anaerobic bacteria in rheumatoid arthritis.

Authors:  I Andersen; H P Olesen
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

5.  Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients.

Authors:  I A Schrijver; Y A De Man; M J Melief; J M Van Laar; H M Markusse; I S Klasen; M P Hazenberg; J D Laman
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

6.  Histology of joint inflammation induced in rats by cell wall fragments of the anaerobic intestinal bacterium Eubacterium aerofaciens.

Authors:  A J Severijnen; R van Kleef; A A Grandia; T H van der Kwast; M P Hazenberg
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

7.  Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora.

Authors:  A J Severijnen; R van Kleef; M P Hazenberg; J P van de Merwe
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 8.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

9.  Small intestinal bacterial overgrowth in patients with rheumatoid arthritis.

Authors:  A E Henriksson; L Blomquist; C E Nord; T Midtvedt; A Uribe
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

10.  Presence of Mycoplasma fermentans in the bloodstream of Mexican patients with rheumatoid arthritis and IgM and IgG antibodies against whole microorganism.

Authors:  Constantino Gil; Antonio Rivera; David Bañuelos; Salvador Salinas; Ethel García-Latorre; Lilia Cedillo
Journal:  BMC Musculoskelet Disord       Date:  2009-08-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.